Difficulty: Medium
Average Score: 81%
Practice
A patient with opioid use disorder arrives to the office-based addiction treatment setting to receive their monthly naltrexone injection and reports having 'a slip' and taking one buprenorphine/naloxone film about a week ago. The patient requests to receive the injection today. Urine toxicology screen is positive for buprenorphine and delta-9-tetrahydrocannabinol. Your best initial reply is:
Correct answer
A
Rationale
Naltrexone (an opioid antagonist) given with recent opioid use (buprenorphine) risks precipitated withdrawal , making it the safest initial response. Proceeding is risky, detox is excessive, and oral naltrexone still poses the same risk.